TNF and COVID-19: Similarly, another study confirmed that several serum pro-inflammatory mediators including IL-2R, IL-6, IL-10, and TNFα are increased in severe (n = 11) compared to moderate (n = 10) COVID-19 patients, while serum IFNγ levels were decreased negatively correlating with disease severity [92].